Literature DB >> 22202101

The role of mTOR signaling in Alzheimer disease.

Salvatore Oddo1.   

Abstract

The buildup of Abeta and tau is believed to directly cause or contribute to the progressive cognitive deficits characteristic of Alzheimer disease. However, the molecular pathways linking Abeta and tau accumulation to learning and memory deficits remain elusive. There is growing evidence that soluble forms of Abeta and tau can obstruct learning and memory by interfering with several signaling cascades. In this review, I will present data showing that the mammalian target of rapamycin (mTOR) may play a role in Abeta and tau induced neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22202101      PMCID: PMC4111148          DOI: 10.2741/s310

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  122 in total

1.  Phosphorylated eukaryotic translation factor 4E is elevated in Alzheimer brain.

Authors:  Xu Li; Wen-Lin An; Irina Alafuzoff; Hilkka Soininen; Bengt Winblad; Jin-Jing Pei
Journal:  Neuroreport       Date:  2004-10-05       Impact factor: 1.837

2.  Regulation of yeast replicative life span by TOR and Sch9 in response to nutrients.

Authors:  Matt Kaeberlein; R Wilson Powers; Kristan K Steffen; Eric A Westman; Di Hu; Nick Dang; Emily O Kerr; Kathryn T Kirkland; Stanley Fields; Brian K Kennedy
Journal:  Science       Date:  2005-11-18       Impact factor: 47.728

3.  The TOR pathway interacts with the insulin signaling pathway to regulate C. elegans larval development, metabolism and life span.

Authors:  Kailiang Jia; Di Chen; Donald L Riddle
Journal:  Development       Date:  2004-07-14       Impact factor: 6.868

4.  Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-beta levels in a mouse model of Alzheimer's disease.

Authors:  Patricia Spilman; Natalia Podlutskaya; Matthew J Hart; Jayanta Debnath; Olivia Gorostiza; Dale Bredesen; Arlan Richardson; Randy Strong; Veronica Galvan
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

5.  Essential role for autophagy protein Atg7 in the maintenance of axonal homeostasis and the prevention of axonal degeneration.

Authors:  Masaaki Komatsu; Qing Jun Wang; Gay R Holstein; Victor L Friedrich; Jun-ichi Iwata; Eiki Kominami; Brian T Chait; Keiji Tanaka; Zhenyu Yue
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-28       Impact factor: 11.205

Review 6.  Polyglutamine diseases: emerging concepts in pathogenesis and therapy.

Authors:  Jieya Shao; Marc I Diamond
Journal:  Hum Mol Genet       Date:  2007-10-15       Impact factor: 6.150

7.  Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway.

Authors:  Pankaj Kapahi; Brian M Zid; Tony Harper; Daniel Koslover; Viveca Sapin; Seymour Benzer
Journal:  Curr Biol       Date:  2004-05-25       Impact factor: 10.834

Review 8.  Autophagy and neurodegeneration: when the cleaning crew goes on strike.

Authors:  Marta Martinez-Vicente; Ana Maria Cuervo
Journal:  Lancet Neurol       Date:  2007-04       Impact factor: 44.182

9.  Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease.

Authors:  Salvatore Oddo; Antonella Caccamo; Masashi Kitazawa; Bertrand P Tseng; Frank M LaFerla
Journal:  Neurobiol Aging       Date:  2003-12       Impact factor: 4.673

Review 10.  The ubiquitin-proteasome system in Alzheimer's disease.

Authors:  Salvatore Oddo
Journal:  J Cell Mol Med       Date:  2008-02-08       Impact factor: 5.310

View more
  73 in total

1.  Constructing and characterizing a bioactive small molecule and microRNA association network for Alzheimer's disease.

Authors:  Fanlin Meng; Enyu Dai; Xuexin Yu; Yan Zhang; Xiaowen Chen; Xinyi Liu; Shuyuan Wang; Lihua Wang; Wei Jiang
Journal:  J R Soc Interface       Date:  2013-12-18       Impact factor: 4.118

2.  Mutant APP and amyloid beta-induced defective autophagy, mitophagy, mitochondrial structural and functional changes and synaptic damage in hippocampal neurons from Alzheimer's disease.

Authors:  P Hemachandra Reddy; XiangLing Yin; Maria Manczak; Subodh Kumar; Jangampalli Adi Pradeepkiran; Murali Vijayan; Arubala P Reddy
Journal:  Hum Mol Genet       Date:  2018-07-15       Impact factor: 6.150

Review 3.  Brain response to calorie restriction.

Authors:  Salvatore Fusco; Giovambattista Pani
Journal:  Cell Mol Life Sci       Date:  2012-12-27       Impact factor: 9.261

4.  Increased Alzheimer's disease-like pathology in the APP/ PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy.

Authors:  Gururaj Joshi; Kok Ann Gan; Delinda A Johnson; Jeffrey A Johnson
Journal:  Neurobiol Aging       Date:  2014-09-06       Impact factor: 4.673

5.  Mammalian target of rapamycin hyperactivity mediates the detrimental effects of a high sucrose diet on Alzheimer's disease pathology.

Authors:  Miranda E Orr; Angelica Salinas; Rochelle Buffenstein; Salvatore Oddo
Journal:  Neurobiol Aging       Date:  2013-12-14       Impact factor: 4.673

6.  Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer's disease.

Authors:  Antonella Caccamo; Ramona Belfiore; Salvatore Oddo
Journal:  Neurobiol Aging       Date:  2018-04-05       Impact factor: 4.673

7.  mTOR and neuronal cell cycle reentry: How impaired brain insulin signaling promotes Alzheimer's disease.

Authors:  Andrés Norambuena; Horst Wallrabe; Lloyd McMahon; Antonia Silva; Eric Swanson; Shahzad S Khan; Daniel Baerthlein; Erin Kodis; Salvatore Oddo; James W Mandell; George S Bloom
Journal:  Alzheimers Dement       Date:  2016-09-29       Impact factor: 21.566

8.  Mammalian target of rapamycin (mTor) mediates tau protein dyshomeostasis: implication for Alzheimer disease.

Authors:  Zhi Tang; Erika Bereczki; Haiyan Zhang; Shan Wang; Chunxia Li; Xinying Ji; Rui M Branca; Janne Lehtiö; Zhizhong Guan; Peter Filipcik; Shaohua Xu; Bengt Winblad; Jin-Jing Pei
Journal:  J Biol Chem       Date:  2013-04-12       Impact factor: 5.157

9.  mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies.

Authors:  Antonella Caccamo; Andrea Magrì; David X Medina; Elena V Wisely; Manuel F López-Aranda; Alcino J Silva; Salvatore Oddo
Journal:  Aging Cell       Date:  2013-03-24       Impact factor: 9.304

Review 10.  The mTOR signalling cascade: paving new roads to cure neurological disease.

Authors:  Peter B Crino
Journal:  Nat Rev Neurol       Date:  2016-06-24       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.